New Report Finds Drug Makers Spent Whopping $6.46 Billion On Advertising In 2018 Big Pharma frequently claims high drug prices are necessary to fund research and development (R&D) for new cures. A new report from Kantar Media underscores what we already know – that Big Pharma’s R&D excuse holds little water and that rising…
Bipartisan Bill Would Take Meaningful Steps To Crack Down On Big Pharma’s Evergreening, Patent Abuse For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington…
Bloomberg Analysis Finds Medicare Spending On 22 Drugs Jumped More Than 500 Percent In Five Years For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C.
Today, the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations held a hearing with representatives of drug manufacturers and pharmacy benefit managers (PBMs) to…
On Wednesday, executives from the three biggest makers of insulin, Novo Nordisk, Eli Lilly and Sanofi, will testify before the U.S. House Committee on Energy and Commerce Subcommittee on Oversight…
For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today after the U.S.
For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday following…
Big Pharma has tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at pharmacy benefit managers (PBMs). As the U.S. Senate Committee on Finance…
For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a bill…
Big Pharma has tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at pharmacy benefit managers (PBMs). As the U.S. Senate Committee on Finance…